STOCK TITAN
  1. Home
  2. News
  3. RVMD

Revolution Medicines Inc - RVMD STOCK NEWS

IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Pricing of $300.0 Million Public Offering of Common Stock
offering
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Commencement of Public Offering of Common Stock
offering
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Update on Corporate Progress
earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2022 After Market Close on February 27, 2023
conferences earnings
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Present at 41st Annual J.P. Morgan Healthcare Conference
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Announces Publication Describing Design and Synthesis of RMC-5552, a First-in-Class, Bi-Steric mTORC1-Selective Inhibitor
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Regain Global Rights to RMC-4630 following Sanofi’s Termination of SHP2 Inhibitor Development and Commercialization Collaboration
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines to Participate in Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
RVMD : Nasdaq
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
earnings
Stock RVMD logo
Revolution Medicines Inc

Nasdaq:RVMD

RVMD Rankings

#1663 Ranked by Market Cap
#2552 Ranked by Stock Gains
N/A Ranked by Dividends

RVMD Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Redwood City

About RVMD

revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.